爱博医疗收盘上涨9.30%，滚动市盈率40.47倍，总市值152.98亿元

Group 1 - The core viewpoint of the article highlights the performance and valuation of Aibo Medical, which closed at 79.1 yuan, up 9.30%, with a rolling PE ratio of 40.47, marking a new low in 53 days, and a total market capitalization of 15.298 billion yuan [1] - Aibo Medical ranks 80th in the medical device industry based on PE ratio, with the industry average at 54.56 and the median at 37.54 [1] - As of March 31, 2025, Aibo Medical had 9,729 shareholders, a decrease of 94 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Aibo Medical focuses on the research, production, sales, and related services of ophthalmic medical devices, with main products including artificial lenses, surgical products, orthokeratology lenses, myopia control products, contact lenses, and other vision care products [1] - The latest quarterly report for Q1 2025 shows Aibo Medical achieved a revenue of 357 million yuan, a year-on-year increase of 15.07%, while net profit was 92.558 million yuan, reflecting a year-on-year decrease of 10.05%, with a gross margin of 64.60% [1]